The FCF Healthcare & Life Sciences Venture Capital Monitor – USA is a monthly published overview of venture capital trends in the US Healthcare & Life Sciences sector.
As of the end of June 2025 we identified the following current VC trends in the United States:
- Total Healthcare & Life Sciences funding reached EUR 19,813m.
- This represents a 5% decline of the funding volume vs. last year continuing the negative trend for Healthcare and Life Sciences funding in the USA in 2025
- Biotech/Pharma received 44% of the total investment volume (EUR 8,766m) with oncology being the leading indication (26%)
- In June, Dispatch Biotherapeutics secured the highest transaction volume with EUR 189m, followed by Athelas with EUR 175m and Commure with EUR 175m
- Subsequently, a mega-financing deal worth the equivalent of USD 1 billion was announced in January for Retro, a biotech company conducting research in the field of the central nervous system
- General Catalyst (United States) is the most active investor (by deal volume in 2025), followed by Illumina (United States) and ARCH Venture Partners (United States)
Capital Markets Research
Healthcare & Life Sciences Venture Capital Monitor – Europe
Monthly Venture capital activities in the European Life Sciences sector
Healthcare & Life Sciences Venture Capital Monitor – USAMonthly Venture capital activities in the US Life Sciences sector
NEWS
FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 07/2025 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 07/2025”. The Monitor is a monthly published overview of venture capital trends in
FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 07/2025 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 07/2024”. The Monitor is a monthly published overview of venture capital trends in the
FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 06/2025 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 06/2025”. The Monitor is a monthly published overview of venture capital trends in
FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 06/2025 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 06/2024”. The Monitor is a monthly published overview of venture capital trends in the
FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 05/2025 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 05/2024”. The Monitor is a monthly published overview of venture capital trends in the
